Oxatomide in dermatology: Review of the main pharmacodynamic and clinical effects;Oxatomide in dermatologia: Revisione dei principali effetti farmacodinamici e clinici

Annali Italiani di Dermatologia Clinica e Sperimentale

Volumn 52, Issue 1, 1998, Pages 9-21

  Stingeni, Luca ^a   Nicora, Mariaflavia ^b   Lisi, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Direzione Medica   (Italy)

Author keywords

Atopic dermatitis; Dermatology; Oxatomide; Review; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIPRURITIC AGENT; OXATOMIDE;

ATOPIC DERMATITIS; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; GEL; HUMAN; ORAL DRUG ADMINISTRATION; REVIEW; TOPICAL DRUG ADMINISTRATION; URTICARIA;

EID: 0031833194     PISSN: 0365169X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Babe KS, Serafin WE. Histamine, bradykinin and their antagonists. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds). The pharmacological basis of therapeutics. New York: Pergamon Press, 1996; 25: 581.
2. Pigatto P. Le orticarie: aspetti fisiopatologici, diagnostici, clinici. Casalnoceto: Editoriale F Folini, 1991.
3. 1-receptor-antagonist drugs. NEJM 1994; 330: 1663.
4. Champion RC. Urticaria. In: Champion RH, Burton JL, Ebling FJG (eds). Textbook of dermatology. Oxford: Blackwell Scientific Publications, 1991; vol III (43): 1865.
5. Hanifin JM, Raika G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (suppl): 44.
6. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic disease. J All Clin Immunol 1995; 96: 302.
7. Bos JD, Kapsenberg ML, Sillevis Smitt JH. Pathogenesis of atopic eczema Lancet 1994; 343: 1338.
8. Oggiano N, Nicora M. L'oxatomide nell'asma bronchiale: rassegna dei principali dati farmacologici e clinici. Pediatria Oggi Med Clur 1997; XVII: 35.
9. Cabotin PP, Janier M. Oxatomide: revue des effets pharmacodynamiques et des effets cliniques en dermatologie. Allergie Immunol 1990; 22: 61.
10. Ohmori K, Ishi H, Takey Y, et al. Pharmacological studies on oxatomide: effect on experimental asthma and Schultz-Dale response in rats and guinea pigs. Folia Pharmacol Jpn 1982; 80: 481.
11. Ohmori K, Ishi H, Shuto K, et al. Pharmacological studies on oxatomide: effects on peripheral organs. Folia Pharmacol Jpn 1983; 81: 79.
12. Gatti S, Coutts A, Francis D, et al. Oxatomide: in vitro assessment of antagonistic activity, and effects on histamine release and enzymatic histamine degradation in skin. Br J Dermatol 1980; 103: 671.
13. Braga PC, Valverde M, Petrigni G, et al. Profilo farmacologico sperimentale e clinico dell'oxatomide. GIMT 1989; 43: 226.
14. Richards DM, Brogden RN, Heel RC, et al. Oxatomide: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1984; 27: 210.
15. Hamasaki Y, Shafigeh M, Yamamoto S, et al. Inhibition of leukotriene synthesis by azelastine. Ann All Asthma Immunol 1996; 76: 469.
16. Kosaka Y, Kawabe H, Ishii A. Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guineapig lung. Agent Actions 1987; 1: 32.
17. Fischer MJE, Paulussen JJC, Horbach DA, et al. Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects. Inflamm Res 1995; 44: 92.
18. Fischer MJE, Paulussen JJC, Roozendaal R, et al. Relation between effects of a set of anti-allergic drug on calcium pathways and membrane structure in Fc e RI activated signal transduction. Inflamm Res 1996; 45: 564.
19. Paulussen JJC, Fischer MJE, Roelofsen EPW, et al. Oxatomide and derivatives as inhibitors of mediator release from a mast cell model. Arzneim-Forsch/Drug Res 1995; 46: 496.
20. Tasaka K, Akagi M, Mio M, et al. Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells (with 1 color plate). Int Arch Allergy Appl Immunol 1987; 83: 348.
21. Paulussen JJC, Fischer MJE, Kok-Van Esterik AE, et al. Influence of the anti-allergic drug oxatomide on the signal transduction mechanism in a mast cell model. Eur J Pharmacol 1996; 312: 121.
22. Church MK, Levi-Schaffer F. Updates on cells and cytokines. J All Clin Immunol 1997; 99: 155.
23. Canonica GW, Ciprandi G. Antiallergic drugs and the immune response. Allergy 1989; 44: 1.
24. Ciprandi G, Cipro G, Paolieri F, et al. Oxatomide does not influence immune response: further support for its use in allergic disorders. Int J Immunother 1987; 3: 301.
25. Ohmori K, Sato S, Nukui E, et al. The effects of an antiallergic drug, oxatomide, on the production and the actions of interleukins in vitro. Jpn J Pharmacol 64 (suppl 1): 481.
26. Kii Y, Inui A, Ito T. Effects of histamine H1 receptor antagonists on action potentials in Guinea-pig isolated papillary muscles. Arch Int Pharmacodyn 1996; 331: 59.